News Image

Dario Expands Pharma Collaborations with Global Pharma Leader to Enhance User Engagement

Provided By PR Newswire

Last update: Nov 4, 2024

The new platform services subscription contract with a top six U.S. pharma client marks a pivotal shift in Dario's pharma channel, transitioning the business model from milestone-based to recurring service subscription fees by expanding engagement with payors and pharmacy benefit managers (PBMs)

Read more at prnewswire.com

DARIOHEALTH CORP

NASDAQ:DRIO (8/1/2025, 8:00:00 PM)

After market: 0.55 +0 (+0.02%)

0.5499

-0.02 (-4.03%)



Find more stocks in the Stock Screener

Follow ChartMill for more